Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.2M
-
Number of holders
-
106
-
Total 13F shares, excl. options
-
69.6M
-
Shares change
-
-8.61M
-
Total reported value, excl. options
-
$151M
-
Value change
-
-$23.1M
-
Put/Call ratio
-
0.54
-
Number of buys
-
45
-
Number of sells
-
-56
-
Price
-
$2.17
Significant Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q3 2021
135 filings reported holding ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share as of Q3 2021.
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) has 106 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 69.6M shares
.
Largest 10 shareholders include RTW INVESTMENTS, LP (7.48M shares), BlackRock Inc. (7.43M shares), Avoro Capital Advisors LLC (6.95M shares), Sonic Fund II, L.P. (6.55M shares), Versant Venture Management, LLC (5.07M shares), VANGUARD GROUP INC (4.38M shares), UBS Group AG (3.14M shares), Artal Group S.A. (3M shares), JPMORGAN CHASE & CO (2.27M shares), and STATE STREET CORP (2.05M shares).
This table shows the top 106 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.